AK119

· Akeso Biopharma

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for AK119, covering 2024-04-25 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]